This website contains forward-looking statements within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based on management’s current beliefs, assumptions, and information available at the time of publication. Forward-looking statements may be identified by words such as “believe,” “expect,” “anticipate,” “intend,” “estimate,” “may,” “will,” “could,” “should,” and similar expressions.

Actual results may differ materially from those expressed or implied by forward-looking statements due to a variety of risks and uncertainties, including but not limited to: the results of clinical trials; regulatory approvals; market conditions; competition; and other factors described in our filings with the U.S. Securities and Exchange Commission, including our most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q.

Oragenics undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future developments, or otherwise, except as required by law.

Nothing on this website constitutes investment advice, a solicitation, or an offer to buy or sell securities. Investors should conduct their own due diligence and consult with a qualified financial advisor before making any investment decisions.

Oragenics, Inc. (NYSE American: OGEN) files reports with the U.S. Securities and Exchange Commission. All SEC filings are available at www.sec.gov and through the Investors section of this website.

Information on this website regarding ONP-002 and other product candidates is intended for informational purposes only. Our product candidates are investigational and have not been approved by the U.S. Food and Drug Administration or any other regulatory authority. Nothing on this website should be construed as a representation that any product candidate will receive regulatory approval or become commercially available.

This website may contain links to third-party websites, including SEC EDGAR, Business Wire, and GlobeNewswire. Oragenics is not responsible for the content, accuracy, or privacy practices of any third-party websites.